AgraFlora Organics Confirms the Receipt of a Health Canada Hemp Production License and Begins Production of High CBD Cultivars to Enhance its Portfolio of Food and Beverage Manufacturing Assets – Dispatch Medical THC Online Calgary Canada

4.6 / 5 - 1329 Avis

VANCOUVER, July 3 2019 / CNW / – AgraFlora Organics International Inc. ( ' AgraFlora " or the " Society ") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a diversified and growth-oriented global cannabis company, is pleased to announce that, following its press release dated May 30, 2019, the Company has obtained a license from Health Canadaunder the Industrial Hemp Regulations of the Cannabis Act (the "Industrial Hemp License" or "LCI") for its Delta Greenhouse Complex with an area of ​​2.2 million square feet.

The industrial hemp license obtained by the company AgraFlora team of immediate capacity in culture, propagation, nursery and formulation / manufacture of the following products:

  • the spread of high quality hemp seedlings for other holders of LCI;
    • thereby ensuring short-term and consistent ancillary cash flows, while solidifying AgraFlora's position as the leading player in cuttings for the North American hemp industry;
    • a proven propagation model designed to produce 1,300,000 low and high density hemp cuttings per 28- to 42-day cycle;
  • the establishment of a nursery dedicated to the spread of hemp within our existing greenhouse infrastructure;
  • the addition of hemp cultivars to high content CBD and cannabinoid-infused beverages to AgraFlora's functional asset portfolio;
    • Edibles and Infusions Corp: the development and manufacture of common food products;
    • the Brewery: the formulation and production of CBD-infused beverages, including non-alcoholic beers seltzers, ready-to-drink beverages ("PAB")
    • Canutra Naturals / HowlBrands: The manufacture of a range of personal care and performance products infused with hemp / CBD oil, including:
      • therapeutic relief balms
      • creams and pain relief rolls infused with CBD;
      • organic cosmetics with anti-aging properties;
      • shampoos and conditioners; and,
      • sun creams
  • the anticipated commercial production of organic hemp seed oil for distribution;
  • experiments and the exclusive development of cultivars with high content in CBD;
    • the collection and storage of high-value strains / seeds for resale initiatives;
  • specialized fiber production;
    • the recovery of hemp stems for processing into high added value products, specialized fibers and building materials.

In conjunction with the hemp and CBD brand's reputable portfolio of assets, as well as its commitment to innovative product development and industrial research, the licensing of industrial hemp further strengthens the mandate of 'AgraFlora to meet global demand for hemp and CBD derived products. AgraFlora will start the research and development process in July 2019, starting with the testing of varieties approved by Health Canada.

AgraFlora expects that, once fully optimized, its industrial hemp operations will provide sufficient raw materials for the Company's unique portfolio of cannabinoid formulation and assets, which will allow the Company to capture significant cash flows in the future. every link in the cannabis chain. The 2.2 million square foot Delta Greenhouse Complex is expected to be one of the largest and most advanced cannabis growing operations in the world, and will serve as a springboard for the continued integration of its complex. upstream, mid-course and downstream capacity.

Mr. Brandon Boddy, CEO of AgraFlora, said, "The Canadian cannabis market is constantly changing. With the the second wave of legalization, of cannabis that will be implemented in October this year and involving edible products, beverages and topical products, we anticipate that demand for CBD will increase significantly.

One of AgraFlora's mandates is to ensure that we can respond to changing legislation and maintain market adaptability while maximizing revenue. We have applied for the hemp license to complete our business model to produce low-cost high-end cannabis and are of the view that the exploitation of existing greenhouse infrastructure to continue the cultivation and spread of hemp will provide the Company with ancillary and stable cash flows.

In collaboration with our experienced partners, the Houwelings Group, we intend to actively begin research and development of a strong hemp cultivar. content in CBD, which will result in a higher yield of CBD and a progressively higher return on investment per acre than the strains that are currently available. "

All hemp crops planned at the Company's Delta plant in British Columbia will utilize existing greenhouse infrastructure that is not currently dedicated to the spread and / or commercial initiatives of cannabis. As a result, AgraFlora's hemp cultivation activities will not affect the current spread and potential cultivation of cannabis. Hemp cultivation will not interfere with planned cannabis grow operations at Delta Greenhouse Complex or reduce the cannabis capacity of this facility.

Further to its press release dated April 29, 2019, the Company issued the second issue of 1,250,000 bonus shares (the "Shares") at a price of $ 0.425 per Cornelius Houwelings share pursuant to a letter from Intention dated May 22, 2018.

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a diversified, growth-oriented global cannabis company. It has an indoor culture facility in London, in Ontario, and is a partner in the Propagation Service Canada joint venture, which owns a large 2,200,000 square foot greenhouse complex in Delta, British Columbia. AgraFlora has been able to create value for its shareholders and is actively seeking other opportunities in the cannabis industry. For more information, please visit:


Brandon Boddy
CEO & President
T: (604) 682-2928

CSE and the Information Service Provider have not reviewed this release and assume no responsibility for its accuracy or suitability.

Caution regarding forward-looking information

With the exception of statements of historical fact, this press release contains certain "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information is often characterized by words such as "plan," "expect," "plan," "intend," "believe," "anticipate," "estimate," and other similar words. , or statements indicating that certain events or conditions "may" or "will" occur. Forward-looking statements are based on opinions and estimates as of the date they are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. statements including, but not limited to, delays or uncertainties regarding regulatory approvals, including those of the CSE. The forward-looking information contains uncertainties, including factors beyond the control of the Company. There can be no assurance that the commercial plans for AgraFlora Organics described in this press release will take effect on the terms and within the time period described in this document. The Company assumes no obligation to update the forward-looking information if management's circumstances, estimates or beliefs change, except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying the risks and uncertainties that may affect the financial results can be found in the Company's filings with the Canadian securities regulatory authorities, available at

SOURCE AgraFlora Organics International Inc.

For further information: AgraFlora Organics International Inc., Tim McNulty, E:, T: (800) 783-6056; For French communication from AgraFlora: Remy Scalabrini, Maricom Inc., E:, T: (888) 585-MARI

Related Links

Here’s what you want to know before visiting your regional medical dispensary:You may require a physician’s recommendation, medical cannabis certification, and/or whatever appropriate documentation is required by your state. Typically, you need to be 18 or older to be eligible for a medical consent, but exceptions may be made in some states for minors with especially debilitating conditions. You will usually enroll with a medicinal dispensary. This is to maintain your medical cannabis recommendation or certification on file for legal and regulatory purposes. There’ll be a waiting room. This is to control the circulation of patients and product, but a straightforward dividing wall gives patients privacy and direct one-on-one contact with a budtender to discuss medical issues. This process can assist budtenders and patients track effective medication in addition to have a living listing of manufacturers and goods for future reference and follow up. Medicinal dispensaries usually permit you to smell and examine the buds before purchase. This may differ from state-to-state.

Yes, municipal approval is necessary before the AGLC will subject a retail cannabis license. Applicants must get in contact with their intended municipality to learn requirements concerning municipal retail cannabis legislation, zoning requirements, land-use limitations, and location requirements regarding how close a retail shop is to a provincial health care centre, college, or parcel of property designated as a school book.
Keep non-medical cannabis legal Adults that are 19 years or older are in a position to:Have up to 30 gram of legal dried cannabis or the equivalent in their own person. Share up to 30 g of legal cannabis with other adults in Canada. Buy cannabis products from a Yukon Liquor Corporation licensed merchant. Grow up to four crops per household. It is illegal to provide non-medical cannabis to anyone below the age of 19 and also for anybody below the age of 19 to have any quantity of anti inflammatory cannabis in Yukon.It is illegal and dangerous to drive while under the influence of cannabis or other intoxicants.